Name: GSM2212069 - Control3 vs Doxorubicin3, 4 week post treatment, forward labelling
Creator: Saket Lab
License: https://www.ncbi.nlm.nih.gov/geo/info/disclaimer.html

GSM2212069 - Control3 vs Doxorubicin3, 4 week post treatment, forward labelling | seqout